Position in FULC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,386,541
+$723,471 QoQ
Shares Held
571,909
+76.6% QoQ
Ownership
0.858%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 168 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FULC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,297,038,010 across 364 Biotechnology names. FULC ranks #185 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in FULC
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,386,541 | 571,909 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,663,070 | 323,879 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $5,394,429 | 586,351 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $7,867,526 | 1,143,536 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,159,487 | 402,600 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $2,548,611 | 542,258 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $3,312,820 | 927,961 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,475,050 | 560,492 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $7,648,948 | 810,270 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $5,882,645 | 871,503 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $1,150,967 | 259,227 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $1,279,515 | 387,732 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $848,760 | 297,811 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $2,296,315 | 315,428 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $2,788,865 | 344,730 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $1,393,094 | 284,305 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $5,620,232 | 237,642 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,501,580 | 84,883 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $1,763,181 | 62,502 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $287,843 | 27,466 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $169,243 | 14,367 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $173,975 | 14,857 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||